Nuchev Pty Ltd (AU:NUC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nuchev Pty Ltd has significantly increased its revenue by 116% quarter-over-quarter to $5.1 million in Q1 FY25, following its acquisition of bWellness. The company saw strong sales growth in both Australia and China, with Oli6® Nutritionals outperforming the general infant formula market. Nuchev’s strategic expansion and diversification efforts are paying off, as it continues to focus on breaking even and capitalizing on major sales events like China’s Double 11.
For further insights into AU:NUC stock, check out TipRanks’ Stock Analysis page.